
			
				Tue  4 November 2025
			
Warszawa (PL)
					 
				
7/6°C
| 
			
				Sun
			
 | 
			
				Mon
			
 | 
			
				Tue
			
 | 
			
				Wed
			
 | 
			
				Thu
			
 | 
| 15 | 
10 | 
11 | 
12 | 
12 | 
 
  
			
				Tue  4 November 2025
			
Praha (CZ)
					 
				
7/4°C
| 
			
				Sun
			
 | 
			
				Mon
			
 | 
			
				Tue
			
 | 
			
				Wed
			
 | 
			
				Thu
			
 | 
| 11 | 
11 | 
13 | 
12 | 
11 | 
 
  
			
				Tue  4 November 2025
			
Bratislava (SK)
					 
				
8/4°C
| 
			
				Sun
			
 | 
			
				Mon
			
 | 
			
				Tue
			
 | 
			
				Wed
			
 | 
			
				Thu
			
 | 
| 17 | 
14 | 
14 | 
14 | 
13 | 
 
  
			
				Tue  4 November 2025
			
Budapest (HU)
					 
				
9/4°C
| 
			
				Sun
			
 | 
			
				Mon
			
 | 
			
				Tue
			
 | 
			
				Wed
			
 | 
			
				Thu
			
 | 
| 19 | 
14 | 
13 | 
13 | 
14 | 
 
  



 
 
 
	
		
		
			
				
				May 12th, 2020
				
				
				Hungarian researchers have concluded the first phase of developing favipiravir, a medication proven effective against cases of the novel coronavirus in Asia. Production of the drug might start as early as this autumn, the innovation and technology ministry said on Tuesday. The infrastructure for clinical tests and manufacturing will be provided by a wide-ranging cooperation between the government, research institutes, universities and companies, the ministry said.
				
				MTI
				
				
				
			
		
		
	
 
 
 
	
		
			
  
		Pageviews this month:
		24,294